- Home
- YOU vs KYMR Comparison
YOU vs KYMR Comparison
Compare YOU & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YOU
- KYMR
- Stock Information
- Founded
- YOU 2010
- KYMR 2015
- Country
- YOU United States
- KYMR United States
- Employees
- YOU N/A
- KYMR N/A
- Industry
- YOU Computer Software: Prepackaged Software
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- YOU Technology
- KYMR Health Care
- Exchange
- YOU Nasdaq
- KYMR Nasdaq
- Market Cap
- YOU 2.4B
- KYMR 2.2B
- IPO Year
- YOU 2021
- KYMR 2020
- Fundamental
- Price
- YOU $26.70
- KYMR $25.97
- Analyst Decision
- YOU Buy
- KYMR Buy
- Analyst Count
- YOU 5
- KYMR 13
- Target Price
- YOU $33.00
- KYMR $56.69
- AVG Volume (30 Days)
- YOU 2.2M
- KYMR 847.3K
- Earning Date
- YOU 05-07-2025
- KYMR 05-01-2025
- Dividend Yield
- YOU 2.69%
- KYMR N/A
- EPS Growth
- YOU 408.65
- KYMR N/A
- EPS
- YOU 1.56
- KYMR N/A
- Revenue
- YOU $770,488,000.00
- KYMR $47,072,000.00
- Revenue This Year
- YOU $15.09
- KYMR $16.24
- Revenue Next Year
- YOU $10.85
- KYMR $22.41
- P/E Ratio
- YOU $17.13
- KYMR N/A
- Revenue Growth
- YOU 25.57
- KYMR N/A
- 52 Week Low
- YOU $16.05
- KYMR $19.45
- 52 Week High
- YOU $38.88
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- YOU 54.62
- KYMR 44.70
- Support Level
- YOU $26.07
- KYMR $24.43
- Resistance Level
- YOU $28.41
- KYMR $26.06
- Average True Range (ATR)
- YOU 1.42
- KYMR 2.36
- MACD
- YOU 0.05
- KYMR 0.41
- Stochastic Oscillator
- YOU 68.39
- KYMR 70.12
About YOU Clear Secure Inc.
Clear Secure Inc is an identity company making experiences safer and easier digitally and physically. It is involved in the creation of a frictionless travel experience while enhancing security. Its secure identity platform uses biometrics to automate the identity verification process through lanes in airports which helps to make the travel experience safe and easy.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.